We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Medical Imaging Health IT Point of Care Business Focus

Hospital Antibiotic Policies Improve Prescription Practices

By HospiMedica International staff writers
Posted on 21 Feb 2017
An updated review of studies identifies effective guidelines and policies to reduce unnecessary use of antibiotics in hospitals.

Researchers at the University of Dundee, University College London, and other institutions searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, and Embase for studies examining the effectiveness and safety of interventions designed to improve antibiotic prescribing to hospital inpatients, and to investigate the effect of different intervention functions. In all, the researchers found 221 studies from the United States, Europe, Asia, South America, and Australia.

The researchers found that interventions broadly fell into two categories; 'restrictive' techniques applied rules to make physicians prescribe properly, whilst 'enabling' techniques provided advice or feedback to help physicians make more informed prescribing decisions. In both cases, the aim of the intervention was to increase the number of appropriate prescribing decisions so that patients who were unlikely to benefit from antibiotics did not get them, whilst they were still used for patients who stood to benefit from them.

The results showed that interventions that included enabling or restrictive techniques were consistently more effective than interventions that relied on simple education alone. Moreover, a synergistic effect existed, with enabling techniques increasing the effectiveness of restrictive techniques. In addition, the interventions shortened duration of antibiotic use from 11 to 9 days per patient, and reduced hospital stay from an average of 13 days to 12 per patient. The review was published on February 9, 2017, in The Cochrane Library.

“We do not need more studies to answer the question of whether these interventions reduce unnecessary antibiotic use, but we do need more research to understand why the most effective behavior change techniques are not more widely adopted within hospital settings,” concluded lead author Peter Davey, PhD, of the UD department of population health sciences. “Appropriate antibiotic use in hospitals should ensure effective treatment of patients with infection, and reduce unnecessary prescriptions.”

For the study, the researchers defined restriction as using rules to reduce the opportunity to engage in the target behavior, or increase the target behavior by reducing the opportunity to engage in competing behaviors. Enablement was defined as increasing the means and reducing the barriers in order to increase capability or opportunity.

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Syringe Pump
SP50 Series
Vessel Sealing Instrument
ERGOseal

Channels

Surgical Techniques

view channel
Illustration of the Hēlo Thrombectomy System device (Photo courtesty of Endovascular Engineering)

FDA-Cleared Thrombectomy System Removes Pulmonary Embolism Clots

Pulmonary embolism occurs when blood clots travel to the lungs and block blood flow, potentially requiring urgent endovascular intervention to prevent death. Catheter-based clot removal can be challenging,... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more